[1]
Malone, E.R. et al. 2021. Predictive radiomics signature for treatment response to nivolumab in patients with advanced renal cell carcinoma. Canadian Urological Association Journal. 16, 2 (Sep. 2021), E94–101. DOI:https://doi.org/10.5489/cuaj.7467.